Identifying Market Opportunities Daily

Company Overview CorMedix is a small-cap biopharmaceutical story that's quietly becoming impossible to ignore. On November 12th - just two weeks ago - the company reported one of the most stunning earnings beats of the quarter: Q3 2025 revenue exploded 810%...

Company Overview Medtronic delivered a stunning earnings beat just hours ago this morning, with fiscal Q2 2026 results that sent shares soaring over 5% to break through $100 - a psychological milestone the stock hasn't reached in over three years. The medical device...

Company Overview Broadcom has emerged as the AI infrastructure winner that many investors overlooked while chasing Nvidia's meteoric rise. In October, the company announced a landmark partnership with OpenAI to deploy 10 gigawatts of custom AI accelerators and...

Company Overview XPeng reported breakthrough Q3 2025 earnings just two days ago on November 17th, delivering results that exceeded expectations across nearly every metric. The Chinese smart EV manufacturer posted revenue of RMB 20.38 billion ($2.86 billion), up 102%...

Company Overview CorMedix reported blockbuster Q3 2025 earnings last Tuesday, November 12th, delivering what may be the most impressive earnings surprise of the entire 2025 biotech reporting season. The company posted EPS of $1.26 versus consensus expectations of just...

Company Overview Lowe's reports its fiscal Q3 2026 earnings tomorrow, Tuesday, November 19th before market open, at a pivotal moment in the company's multi-year transformation. The home improvement retailer recently completed its $8.8 billion acquisition of Foundation...

Company Overview Nvidia reports its fiscal Q3 2026 earnings on Tuesday, November 19th after market close, and anticipation is reaching fever pitch for what may be the most important earnings report of the entire season. As the world's most valuable company and the...

Company Overview Quantum Computing Inc. reports its Q3 2025 earnings after today's market close, and Wall Street is watching closely after the stock's explosive 300%+ surge over the past year. The company specializes in integrated photonics and thin-film lithium...

Company Overview CVS Health represents one of 2025's most dramatic corporate turnarounds, with shares rebounding approximately 40% year-to-date after crashing 43% in 2024 amid disappointing quarterly results and elevated medical costs in its Aetna insurance business....

Company Overview Instacart received a major vote of confidence this morning when BMO Capital Markets upgraded the stock to Outperform from Market Perform with a $58 price target - representing approximately 55% upside from current levels around $37. The upgrade comes...